A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113)

National Institute of Allergy and Infectious Diseases (NIAID)

Status: Withdrawn

Conditions: HIV Infections

Treatments: Drug: Indinavir sulfate

Study type: Interventional

Funder types: NIH

Identifiers

NCT00000804

L DRUG

Details and patient eligibility

About

The purpose of this trial is to study L-735,524, which is an inhibitor of the HIV protease enzyme. It will be used with interleukin-2 in patients infected with HIV.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria